We have read the article by Michalsen et al. (2006) . published in European Journal of Clinical Nutrition on the effects of Mediterranean Diet on plasma biomarkers of inflammation in coronary patients. They reported an apparent lack of effect of a Mediterranean diet on inflammatory biomarkers related to vascular injury and also on metabolic plasma molecules. This paper has suggested us several comments.
First, as it has been highlighted recently in several reports, olive oil is the main common dietary component in the socalled Mediterranean diets, which have many variants in both sides of the Mediterranean Sea (Nestle, 1995; Trichopoulou and Lagiou, 1997) . However, a decrease in oleic acid (18:1, n-9) was observed in the mentioned study, not only in the quantification of nutrients after 1 year, but also in its plasma levels in the intervention group as compared with the control group. Virgin olive oil in the diet can be directly associated with a lower risk of a first myocardial infarction (Fernández-Jarne et al., 2002) . This might be not only due to its content in oleic acid, but also to the antioxidant and antiinflammatory effects of its polyphenolic components (Marrugat et al., 2004) . Oleic acid by itself diminishes vascular cellular adhesion molecule-1 membrane expression and nuclear factor-kB activation in endothelial cells (Carluccio et al., 1999) . As the authors state in the paper, without providing free specific supplements, it could be difficult to reach an increase in dietary Alpha Linolenic Acid in Germany, and we suspect that this could also be true for virgin olive oil.
Second, the randomized intervention is not designed for comparing Mediterranean diet with either control diet or occidental type pattern of feeding. Both arms are treated with the same dietary intervention, differing in the intensity of the education programme. While the experimental group received 100 h of education, the control group was advised by written information to follow a Mediterranean diet. As a consequence of this design, we would say that the lack of effect on reduction of inflammatory molecules was due to a failure of the intensive education programme, instead of a lack of effect of the intervention with Mediterranean diet on vascular inflammation. Patients are aware of the effect of diet on the atherosclerosis process, and many control group patients could have an increased motivation to take care of their dietary habits after the written advice.
We have found an apparent association of the levels of inflammatory markers in blood drawn from coronary sinus with the mean content of olive oil in the diet and also with a Mediterranean dietary score, in unstable angina patients (Serrano-Martínez et al., 2005) . In this group, a significant correlation of the extension of coronary damage with monocyte chemoattractant protein-1 level in blood from coronary sinus was also obtained (Serrano-Martínez et al., 2003) . These findings indirectly point to a mechanistic explanation of the effect of the Mediterranean food pattern on the extent of the coronary disease.
In We thank Drs Serrano-Martinez and Martinez-Gonzalez for their comments concerning our recently published study. They point to limitations that are an inherent part of a clinical randomized trial in a population under other behavioural influences and treatments. We fully agree that for both dietary oleic acid and ALA, there is large evidence of potential beneficial effects in the pathogenesis and progression of atherosclerosis and relevant biomarkers. However, our goal was to assess the impact of an intensified dietary approach, which emphasizes a Mediterranean diet in a pragmatic way -namely in a medically treated patient sample of a non-Mediterranean region. In this setting, we could not find an effect of our dietary programme on markers of inflammation and metabolic risk, which, at least, implicates that a clinical relevant effect will not be easy to obtain in such populations.
Drs Serrano-Martinez and Martinez-Gonzalez rightly point to the limitation that the education may have failed in some regards and, to the contrary, the control group may have also changed their diet. Of note, subtotal adherence and restriction are not only an inherent part of clinical trials but also a problematic part of the real-life scenario in treating and advising patients. On the other hand, correlation analysis of the whole study population also revealed no associations between the diet and the measured biomarkers.
As already expressed in the article, our results do not preclude beneficial effects of the Mediterranean diet on the measured markers. The Mediterranean diet still should be regarded as an effective tool for primary and secondary prevention in coronary artery disease. However, to give the medically treated coronary patient an estimate of its current clinical impact, further studies seem necessary.
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